儿童新型冠状病毒感染诊断、治疗和预防专家共识(第五版)  

Diagnosis,treatment and prevention of severe acute respiratory syndrome coronavirus 2 infection in children:experts′consensus statement(Fifth Edition)updated for the Omicron variant

作　　者：蒋荣猛 谢正德 姜毅[3] 陆小霞 金润铭[5] 郑跃杰[6] 尚云晓[7] 徐保平[8] 刘智胜[9] 卢根 邓继岿[11] 刘光华 王晓川[13] 王建设 冯录召 刘薇[16] 郑毅 舒赛男[18] 陆敏[19] 罗万军[20] 刘苗[3] 崔玉霞[21] 叶乐平 申阿东 刘钢[24] 高立伟[8] 熊莉娟 白燕[5] 林丽开 魏庄[27] 薛凤霞 王天有 赵东赤[29] 赵正言[30] 邵剑波[31] 黄永坚[32] 何颜霞[33] 李兴旺 杨永弘[6,23] 申昆玲 Jiang Rongmeng;Xie Zhengde;Jiang Yi;Lu Xiaoxia;Jin Runming;Zheng Yuejie;Shang Yunxiao;Xu Baoping;Liu Zhisheng;Lu Gen;Deng Jikui;Liu Guanghua;Wang Xiaochuan;Wang Jianshe;Feng Luzhao;Liu Wei;Zheng Yi;Shu Sainan;Lu Min;Luo Wanjun;Liu Miao;Cui Yuxia;Ye Leping;Shen Adong;Liu Gang;Gao Liwei;Xiong Lijuan;Bai Yan;Lin Likai;Wei Zhuang;Xue Fengxia;Wang Tianyou;Zhao Dongchi;ZhaoZhengyan;Shao Jianbo;Gary Wingkin Wong;He Yanxia;Li Xingwang;Yang Yonghong;Shen Kunling(Diagnosis and Treatment Center of Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,China;Beijing Key Laboratory of Pediatric Respiratory Infection Diseases,Key Laboratory of Major Diseases in Children,Ministry of Education,National Clinical Research Center for Respiratory Diseases,Research Unit of Critical Infection in Children,Chinese Academy of Medical Sciences,2019RU016,Laboratory of Infection and Virology,Beijing Pediatric Research Institute,Beijing Children′s Hospital,Capital Medical University,National Center for Children′s Health,Beijing 100045,China;Department of Pediatrics,Renmin Hospital of Wuhan University,Wuhan 430060,China;Department of Respiratory,Wuhan Children′s Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430016,China;Department of Pediatrics,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Respiratory,Shenzhen Children′s Hospital,Shenzhen 518038,China;Department of Pediatric Respiratory,Shengjing Hospital Affiliated to China Medical University,Shenyang 110004,China;Department of Respiratory,Beijing Children′s Hospital,Capital Medical University,National Clinical Research Center for Respiratory Diseases,National Center for Children′s Health,Beijing 100045,China;Department of Neurology,Wuhan Children′s Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430016,China;Department of Respiratory,Guangzhou Women and Children′s Medical Center,Guangzhou 510623,China;D

机构地区：[1]首都医科大学附属北京地坛医院感染性疾病诊疗中心,北京100015 [2]国家儿童医学中心(北京),首都医科大学附属北京儿童医院,北京市儿科研究所,中国医学科学院儿童危重感染诊治创新单元,国家呼吸系统疾病临床医学研究中心,儿科重大疾病研究教育部重点实验室,儿童呼吸道感染性疾病研究北京市重点实验室,北京100045 [3]武汉大学人民医院儿科,武汉430060 [4]华中科技大学同济医学院附属武汉儿童医院呼吸科,武汉430016 [5]华中科技大学同济医学院附属协和医院儿科,武汉430022 [6]深圳市儿童医院呼吸科,深圳518038 [7]中国医科大学附属盛京医院小儿呼吸内科,沈阳110004 [8]国家儿童医学中心(北京),国家呼吸系统疾病临床医学研究中心,首都医科大学附属北京儿童医院呼吸科,北京100045 [9]华中科技大学同济医学院附属武汉儿童医院神经内科,武汉430016 [10]广州市妇女儿童医疗中心呼吸科,广州510623 [11]深圳市儿童医院感染科,深圳518038 [12]上海儿童医学中心福建医院,福建省儿童医院儿科,福州350005 [13]国家儿童医学中心(上海),复旦大学附属儿科医院临床免疫/过敏科,上海201102 [14]复旦大学附属儿科医院感染传染科,上海201102 [15]中国医学科学院北京协和医学院群医学及公共卫生学院,北京100730 [16]天津大学儿童医院,天津市儿童医院,天津300134 [17]首都医科大学附属北京安定医院,国家精神心理疾病临床医学研究中心,精神疾病诊断与治疗北京市重点实验室,北京100088 [18]华中科技大学同济医学院附属同济医院儿科,武汉430030 [19]上海市儿童医院呼吸科,上海200062 [20]华中科技大学同济医学院附属武汉儿童医院感染管理办公室,武汉430016 [21]贵州省人民医院儿科,贵阳550002 [22]北京大学第一医院儿科,北京100034 [23]国家儿童医学中心(北京),国家呼吸系统疾病临床医学研究中心,�

出　　处：《中华实用儿科临床杂志》2023年第1期20-30,共11页Chinese Journal of Applied Clinical Pediatrics

基　　金：国家自然科学基金(72174138);北京市卫健委高层次公共卫生技术人才建设项目(2022-2-002)

摘　　要：2023年1月8日起,我国将2019新型冠状病毒病(COVID-19)列为法定乙类传染病管理范畴,并按照乙类管理。鉴于目前奥密克戎变异株为我国主要流行病毒株,为与时俱进地指导儿童新型冠状病毒(SARS-CoV-2)感染的救治工作,参考《新型冠状病毒感染诊疗方案(试行第十版)》《儿童新型冠状病毒感染诊断、治疗和预防专家共识(第四版)》和儿科相关病毒感染诊疗策略,特制订《儿童新型冠状病毒感染诊断、治疗和预防专家共识(第五版)》,对相关病原学、流行病学、致病机制、临床表现、辅助检查、诊断、治疗等内容进行了相应更新,新增了COVID-19相关脑病、暴发性心肌炎等严重并发症的救治要点,供临床参考。China has classified the Corona Virus Disease 2019(COVID-19)as a statutory category B infectious disease and managed it according to Category B since January 8,2023.In view that Omicron variant is currently the main epidemic strain in China,in order to guide the treatment of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection in children with the times,refer to the Diagnosis and Treatment Protocol for Novel Coronavirus Infection(Trial 10 th Edition),Expert Consensus on Diagnosis,Treatment and Prevention of Novel Coronavirus Infection in Children(Fourth Edition)and the Diagnosis and Treatment Strategy for Pediatric Related Viral Infections.The Expert Consensus on the Diagnosis,Treatment and Prevention of Novel Coronavirus Infection in Children(Fifth Edition)has been formulated and updated accordingly on related etiology,epidemiology,pathogenic mechanism,clinical manifestations,auxiliary examination,diagnosis and treatment,and added key points for the treatment of COVID-19 related encephalopathy,fulminating myocarditis and other serious complications for clinical reference.

关 键 词：新型冠状病毒感染 儿童 奥密克戎变异株 诊断 治疗 预防 共识 

分 类 号：R725.6[医药卫生—儿科]